3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase 3
7
Phase 1
7
Phase 1/2
2
Phase NA
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Solitary Fibrous Tumors
1
Sarcoma, Synovial
1
Sarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangioendothelioma
1
Interventions
Ifosfamide
8
Doxorubicin
8
Blood Specimen Collection
8
Radiosurgery
7
Proton Therapy
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Standard of Care
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
X-Rays
3
Vincristine
3
Radiation Dose Hypofractionation
3
Palliative Care
3
Methods
3
Mesna
3
pegfilgrastim
2
pazopanib
2
dexamethasone acetate
2
Trastuzumab
2
Transurethral Resection of Bladder
2
Restraint, Physical
2
Radiotherapy, Intensity-Modulated
2
Protons
2
Practice Guidelines as Topic
2
Neoadjuvant Therapy
2
Methotrexate
2
Melphalan
2
Heavy Ion Radiotherapy
2
Gene Expression Profiling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Sarcoma
×
Trabectedin
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled